Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Jan;9(1):487-489.e1.
doi: 10.1016/j.jaip.2020.09.050. Epub 2020 Oct 9.

Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak

Manuel Jorge Rial  1 , Marcela Valverde  2 , Victoria Del Pozo  3 , Francisco Javier González-Barcala  4 , Carlos Martínez-Rivera  5 , Xavier Muñoz  6 , José María Olaguibel  7 , Vicente Plaza  8 , Elena Curto  8 , Santiago Quirce  9 , Pilar Barranco  9 , Javier Domínguez-Ortega  9 , Joaquin Mullol  10 , César Picado  11 , Antonio Valero  11 , Irina Bobolea  11 , Ebymar Arismendi  11 , Paula Ribó  11 , Joaquín Sastre  12
Affiliations
Multicenter Study

Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak

Manuel Jorge Rial et al. J Allergy Clin Immunol Pract. 2021 Jan.
No abstract available

PubMed Disclaimer

References

    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. - PMC - PubMed
    1. Matsumoto K., Saito H. Does asthma affect morbidity or severity of COVID-19? J Allergy Clin Immunol. 2020;146:55–57. - PMC - PubMed
    1. Kimura H., Francisco D., Conway M., Martinez F.D., Vercelli D., Billheimer D., et al. Type 2 inflammation modulates ACE2 and TMPRSS2, mediators of SARS-CoV-2 entry and fusion, in airway epithelial cells. J Allergy Clin Immunol. 2020;146:80–88.e8. - PMC - PubMed
    1. Global Initiative for Asthma Global strategy for asthma management and prevention. 2019. www.ginasthma.org Available from: Accessed July 16, 2020.
    1. Barroso B., Valverde-Monge M., Cañas J.A., Rodrigo-Muñoz J.M., Gonzalez-Cano B., Villalobos-Violan V., et al. Presenting prevalence, characteristics and outcome of asthmatic patients with T2 diseases in hospitalized subjects with COVID-19 in Madrid, Spain. J Investig Allergol Clin Immunol. 2020;30:382–384. - PubMed

Publication types

Substances